Epimacular brachytherapy for wet AMD: current perspectives

References

• FurtadoJMLansinghVCCarterMJCauses of blindness and visual impairment in Latin AmericaSurv Ophthalmol201257214917722137039
   PubMed Web of Science ®Google Scholar
• VirgiliGDoDVBresslerNMMenchiniUNew therapies for neovascular age-related macular degeneration: critical appraisal of current evidenceActa Ophthalmol Scand200785162017244204
   PubMedGoogle Scholar
• ProkofyevaEZrennerEEpidemiology of major eye diseases leading to blindness in Europe: a literature reviewOphthalmic Res201247417118822123077
   PubMed Web of Science ®Google Scholar
• RudnickaARJarrarZWormaldRCookDGFletcherAOwenCGAge and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysisOphthalmology2012119357158022176800
   PubMed Web of Science ®Google Scholar
• Spanish Eyes Epidemiological (SEE) Study GroupPrevalence of age-related macular degeneration in SpainBr J Ophthalmol201195793193621216795
   PubMed Web of Science ®Google Scholar
• KleinRKleinBEKnudtsonMDMeuerSMSwiftMGangnonREFifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye StudyOphthalmology2007114225326217270675
   PubMed Web of Science ®Google Scholar
• SmithWAssinkJKleinRRisk factors for age-related macular degeneration: pooled findings from three continentsOphthalmology2001108469770411297486
   PubMed Web of Science ®Google Scholar
• FriedmanDSKatzJBresslerNMRahmaniBTielschJMRacial differences in the prevalence of age-related macular degeneration: the Baltimore Eye SurveyOphthalmology199910661049105510366070
   PubMed Web of Science ®Google Scholar
• KawasakiRYasudaMSongSJThe prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysisOphthalmology2010117592192720110127
   PubMed Web of Science ®Google Scholar
• GehrsKMAndersonDHJohnsonLVHagemanGSAge-related macular degeneration: emerging pathogenetic and therapeutic conceptsAnn Med200638745047117101537
   PubMed Web of Science ®Google Scholar
• LimLSMitchellPSeddonJMHolzFGWongTYAge-related macular degenerationLancet201237998271728173822559899
   PubMed Web of Science ®Google Scholar
• BiarnésMMonésJAlonsoJAriasLUpdate on geographic atrophy in age-related macular degenerationOptom Vis Sci201188788188921532519
   PubMed Web of Science ®Google Scholar
• LuMAdamisAPMolecular biology of choroidal neovascularizationOphthalml Clin North Am2006193323334
   Google Scholar
• FerraraNMassRDCampaCKimRTargeting VEGF-A to treat cancer and age-related macular degenerationAnnu Rev Med20075849150417052163
   PubMed Web of Science ®Google Scholar
• OlssonAKDimbergAKreugerJClaesson-WelshLVEGF receptor signalling-in control of vascular functionNat Mol Cell Biol200675359371
   PubMed Web of Science ®Google Scholar
• NgEWMShimaDTCaliasPCunninghamETJrGuyerDRAdamisAPPegaptanib, a targeted anti-VEGF aptamer for ocular vascular diseaseNat Drug Disc200652123132
   PubMed Web of Science ®Google Scholar
• FerraraNDamicoLShamsNLowmanHKimRDevelopment of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degenerationRetina200626885987017031284
   PubMed Web of Science ®Google Scholar
• RosenfeldPJNew treatments for age-related macular degenerationLancet20073709597147917964340
   PubMed Web of Science ®Google Scholar
• BrowningDJKaiserPKRosenfeldPJStewartMWAflibercept for age-related macular degeneration: a game-changer or quiet addition?Am J Ophthalmol2012154222222622813448
   PubMed Web of Science ®Google Scholar
• De JongPTAge-related macular degenerationN Engl J Med2006355141474148517021323
   PubMed Web of Science ®Google Scholar
• KleinRCruickshanksKJNashSDThe prevalence of age-related macular degeneration and associated risk factorsArch Ophthalmol2010128675075820547953
   PubMedGoogle Scholar
• ChakravarthyUWongTYFletcherAClinical risk factors for age-related macular degeneration: a systematic review and meta-analysisBMC Ophthalmol2010103121144031
   PubMed Web of Science ®Google Scholar
• ReynoldsRRosnerBSeddonJMSerum lipid biomarkers and hepatic lipase gene associations with age-related macular degenerationOphthalmology2010117101989199520888482
   PubMed Web of Science ®Google Scholar
• BarkerFMDietary supplementation: effects on visual performance and occurrence of AMD and cataractsCurr Med Res Opin20102682011202320590393
   PubMed Web of Science ®Google Scholar
• RatnapriyaRChewEYAge-related macular degeneration-clinical review and genetics updateClin Genet201384216016623713713
   PubMed Web of Science ®Google Scholar
• DeWanABrackenMBHohJTwo genetic pathways for age-related macular degenerationCurr Opin Genet Dev200717322823317467263
   PubMed Web of Science ®Google Scholar
• MontezumaSRSobrinLSeddonJMReview of genetics in age related macular degenerationSemin Ophthalmol200722422924018097986
   PubMedGoogle Scholar
• DingXPatelMChanCCMolecular pathology of age-related macular degenerationProg Retin Eye Res200928111819026761
   PubMed Web of Science ®Google Scholar
• TuoJGrobSZhangKChanCCGenetics of immunological and inflammatory components in age-related macular degenerationOcul Immunol Inflamm2012201273622324898
   PubMed Web of Science ®Google Scholar
• LiuMMChanCCTouJGenetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial geneticsHum Genomics20123161323244519
   PubMed Web of Science ®Google Scholar
• SeddonJMGenetic and environmental underpinnings to age-related ocular diseasesInvest Ophthalmol Vis Sci20135414ORSF283024335064
   PubMed Web of Science ®Google Scholar
• ZarbinMACurrent concepts in the pathogenesis of age related macular degenerationArch Ophthalmol2004122459861415078679
   PubMed Web of Science ®Google Scholar
• ZarbinMARosenfeldPJPathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternativesRetina20103091350136720924259
   PubMed Web of Science ®Google Scholar
• ZarbinMPathogenesis of age-related macular degenerationBandelloFQuerquesGMedical RetinaESASO Course SeriesBaselKarger20121125133
   Google Scholar
• KleinRJZeissCChewEYComplement factor H polymorphism in age related macular degenerationScience2005308572038538915761122
   PubMed Web of Science ®Google Scholar
• HainesJLHauserMASchmidtSComplement factor H variant increases the risk of age-related macular degenerationScience2005308572041942115761120
   PubMed Web of Science ®Google Scholar
• GoldBMerriamJEZernantJAMD Genetics Clinical Study GroupVariation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degenerationNat Genet200638445846216518403
   PubMed Web of Science ®Google Scholar
• MallerJBFagernessJAReynoldsRCNealeBMDalyMJSeddonJMVariation in complement factor 3 is associated with risk of age-related macular degenerationNat Genet200739101200120117767156
   PubMed Web of Science ®Google Scholar
• SivaprasadSHykinPWhat is new in the management of wet age-related macular degeneration?Br Med Bull201310520121123393060
   PubMed Web of Science ®Google Scholar
• EnglanderMKaiserPKCombination therapy for the treatment of neovascular age-related macular degenerationCurr Opin Ophthalmol201324323323823429601
   PubMed Web of Science ®Google Scholar
• StannardCSauerweinWMareeGLecuonaKRadiotherapy for ocular tumourEye201327211912723174750
   PubMed Web of Science ®Google Scholar
• SilvaRAMoshfeghiAAKaiserPKSinghRPMoshfeghiDMRadiation treatment for age-related macular degenerationSemin Ophthalmol201126312113021609224
   PubMed Web of Science ®Google Scholar
• KirwanJFConstablePHMurdochIEKhawPTBeta irradiation: new uses for an old treatment: a reviewEye20031720721512640408
   PubMed Web of Science ®Google Scholar
• RomboutsCAertsABeckMDifferential response to acute low dose radiation in primary and immortalized endothelial cellsInt J Radiat Biol2013891084185023692394
   PubMed Web of Science ®Google Scholar
• GrossniklausHEMartinezJABrownVBImmunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degenerationAm J Ophthalmol199211444644721415458
   PubMed Web of Science ®Google Scholar
• EmamiBLymanJBrownATolerance of normal tissue to therapeutic irradiationInt J Radiat Oncol Biol Phys19912111091222032882
   PubMed Web of Science ®Google Scholar
• GunduzKShieldsCLShieldsJACaterJFreireJEBradyLWRadiation retinopathy following plaque radiotherapy for posterior uveal melanomaArch Ophthalmol1999117560961410326957
   PubMedGoogle Scholar
• A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD study). Radiation Therapy for Age-Related Macular DegenerationOphthalmology1999106122239224710599652
   PubMed Web of Science ®Google Scholar
• ArchambeauJOMaoXWYonemotoLTWhat is the role of radiation in the treatment of subfoveal membranes: review of radiobiologic, pathologic, and other considerations to initiate a multimodality discussionInt J Radiat Oncol Biol Phys1998405112511369539568
   PubMed Web of Science ®Google Scholar
• LambooijACKuijpersRWMooyCMKliffenMRadiotherapy of exudative age-related macular degeneration: a clinical and pathologic studyGraefes Arch Clin Exp Ophthalmol2001239753954311521699
   PubMed Web of Science ®Google Scholar
• KishanAUModjtahediBSMorseLSLeePRadiation therapy for neovascular age-related macular degenerationInt J Radiat Oncol Biol Phys201385358359722975610
   PubMed Web of Science ®Google Scholar
• HartPMArcherDBChakravarthyUAsymmetry of disciform scarring in bilateral disease when one eye is treated with radiotherapyBr J Ophthalmol19957965625687542916
   PubMed Web of Science ®Google Scholar
• IvanovVNZhouHGhandhiSAKarasicTBYaghoubianBAmundsonSARadiation-induced bystander signaling pathways in human fibroblasts: a role for interleukin-33 in the signal transmissionCell Signal20102271076108720206688
   PubMed Web of Science ®Google Scholar
• RegilloCDBrownDMAbrahamPRandomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study Year 1Am J Ophthalmol2008145223924818222192
   PubMed Web of Science ®Google Scholar
• FingerPTBersonANgTSzechterAOphthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularizationAm J Ophthalmol1999127217017710030559
   PubMed Web of Science ®Google Scholar
• JaakkolaAHeikkonenJTommilaPLaatikainenLImmonenIStrontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomized studyOphthalmology2005112456757315808245
   PubMed Web of Science ®Google Scholar
• LommatzschPKWerschnikCSchusterELong-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanomaGraefes Arch Clin Exp Ophthalmol2000238212913710766281
   PubMed Web of Science ®Google Scholar
• PetrarcaRJacksonTLRadiation therapy for neovascular age-related macular degenerationClin Ophthalmol20115576321311657
   PubMedGoogle Scholar
• CantonVMQuiroz-MercadoHVelez-MontoyaR24-Gy low-voltage X-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomesOphthalmic Surg Lasers Imaging2012431202422251841
   PubMedGoogle Scholar
• ColeCJCharterisDGCataract extraction after retinal detachment repair by vitrectomy: visual outcome and complicationsEye20092361377138118776865
   PubMed Web of Science ®Google Scholar
• RobisonCDKrebsIBinderSVitreomacular adhesion in active and end-stage age-related macular degenerationAm J Ophthalmol20091481798219327744
   PubMed Web of Science ®Google Scholar
• StefanssonELandersMB3rdWolbarshtMLIncreased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomyTrans Am Ophthalmol Soc1981793073347200671
   PubMedGoogle Scholar
• JampolLMOxygen therapy and intraocular oxygenationTrans Am Ophthalmol Soc1987854074373447339
   PubMedGoogle Scholar
• NordsmarkMOvergaardMOvergaardJPretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neckRadiother Oncol199641131398961365
   PubMed Web of Science ®Google Scholar
• AvilaMPFarahMESantosADupratJPWoodwardBWNauJTwelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degenerationBr J Ophthalmol200993330530919019935
   PubMed Web of Science ®Google Scholar
• AvilaMPFarahMESantosAThree-year safety and visual acuity results of epimacular 90 strontium/90 Yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degenerationRetina2012321101821817963
   PubMed Web of Science ®Google Scholar
• DugelPUPetrarcaRBennettMMacular epiretinal brachytherapy in treated age-related macular degeneration: MERITAGE study: Twelve-month safety and efficacy resultsOphthalmology201211971425143122465819
   PubMed Web of Science ®Google Scholar
• PetrarcaRDugelPUBennettMMacular epiretinal brachytherapy in treated age-related macular degeneration (MERITAGE): month 24 safety and efficacy resultsRetina201434587487924169101
   PubMedGoogle Scholar
• DugelPUBebchukJDNauJCABERNET Study GroupEpimacular brachytherapy for neovascular age-related macular degeneration: a randomized, controlled trial (CABERNET)Ophthalmology2013120231732723174399
   PubMed Web of Science ®Google Scholar